Literature DB >> 10457050

The road to Rome.

W G Thompson1.   

Abstract

Mesh：

Year:  1999        PMID： 10457050      PMCID： PMC1766687          DOI： 10.1136/gut.45.2008.ii80

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.

Authors:  Stefan Müller; Maya Styner; Beatrice Seibold-Schmid; Beatrice Flogerzi; Michael Mähler; Astrid Konrad; Frank Seibold
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

Review 3.  Irritable bowel syndrome.

Authors:  Antonella Spinelli
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Authors:  Matthew Corbitt; N Campagnolo; D Staines; S Marshall-Gradisnik
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

5.  Evaluation and management of constipation.

Authors:  David E Beck
Journal:  Ochsner J       Date:  2008

6.  Effect of modified Sinisan on anorectal manometry of the constipation predominant type of irritable bowel syndrome.

Authors:  Su-ping Yu; Hui Ye; Nan-lin Ha; Shu-qing Ding; Gao Chen
Journal:  Chin J Integr Med       Date:  2005-03       Impact factor: 1.978

7.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 8.  Clinical practice: diagnosis and evaluation of dyspepsia.

Authors:  David Yates Graham; Massimo Rugge
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

9.  The evaluation of constipation.

Authors:  Matthew D Vrees; Eric G Weiss
Journal:  Clin Colon Rectal Surg       Date:  2005-05

Review 10.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.